XenoTherapeutics Company
XenoTherapeutics is a clinical-stage cell and gene therapy company engineering immune-compatible cells, tissues, and organs. XenoTherapeutics conducts all phases of clinical product development, from initial genome engineering to prototype design, from manufacturing to clinical evaluation. We Engineer Life. In 2019, XenoTherapeutics successfully completed the first ever FDA-cleared genetically engineered non-human organ transplant for investigational use.
Industry:
Gene therapy
Technology:
Others
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Headquarters:
Boston, Massachusetts, United States
Employee Number:
1-10
Founded Date:
2016-01-04
Last Funding Type:
Seed